Lidet (Naproxen)

Naproxen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels, the drug diminishes the inflammatory response, reduces swelling, and lessens the sensation of pain.

The specific dosage of Lidet is determined by the prescribing healthcare professional based on the individual’s condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Naproxen is generally classified as a pregnancy‑category drug that should be avoided, especially in the third trimester, due to potential risks to the fetus. It is also excreted in breast milk, so breastfeeding mothers should consult their physician before using naproxen.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen has a longer half‑life, allowing less frequent dosing, whereas ibuprofen often requires multiple daily doses. Safety profiles are comparable, but individual patient factors may favor one over the other.

Lidet should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, and store them away from direct sunlight to maintain potency.

Lidet is taken orally with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. The tablet should be swallowed whole and not chewed or crushed.

Serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, acute kidney injury, severe skin reactions, and hepatic dysfunction. Patients should seek immediate medical attention if they experience symptoms like black stools, chest pain, sudden swelling, or rash.

Naproxen is contraindicated in individuals with known hypersensitivity to NSAIDs, active gastrointestinal ulcer disease, severe heart failure, or significant renal impairment. It should also be avoided by patients on certain anticoagulants or those with a history of serious cardiovascular events unless specifically directed by a physician.